Stock vs Stock Comparison

HCA Healthcare, Inc. vs Eli Lilly and Company

HCA and LLY are evenly matched across key metrics.

HCA$367.35
LLY$1064.15

🏆 Tale of the Tape

44
HCALLY
9.0%Profitability (Net Margin)31.7%
13.0xValuation (P/E)39.2x
21.5%Efficiency (ROIC)30.4%
7/9Health (Piotroski F)7/9
2.8Safety (Altman Z)7.8
7.1%Growth (Rev YoY)44.7%
1.41Risk (Sharpe 1Y)0.61
-22.91xBalance Sheet (D/E)3.24x
5.08%FCF Yield0.68%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

-0.005
252-Day Correlation
-0.047
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricHCALLY
Market Cap$84.0B$985.4B
P/E Ratio13.0x39.2x
Forward P/E11.4x24.8x
P/B-13.36x31.65x
Dividend Yield0.82%0.63%
Beta1.190.48

Quantitative Metrics

MetricHCALLY
DCF Fair Value$853.10$296.11
DCF Upside+71.5%-68.2%
Piotroski F7/97/9
Altman Z2.817.84
Beneish M-2.95-1.91
FCF Yield5.08%0.68%
Net Debt/EBITDA2.6x1.1x
ROIC21.5%30.4%
WACC10.7%7.8%
ROIC – WACC10.8pp22.5pp
Gross Margin41.5%83.0%
Net Margin9.0%31.7%
Rev Growth YoY7.1%44.7%
Sharpe (1Y)1.410.61
Max Drawdown 3Y
FCF Payout Ratio9%90%

HCA Price

Loading chart...

LLY Price

Loading chart...

ETF Exposure

HCA found in:

XHS1.31%
XLV1.15%
VHT1.12%
VFMO0.74%
VFVA0.46%
MGV0.34%
SCHV0.28%
VTV0.27%
RSP0.20%
IWD0.20%
SPYG0.18%
ONEO0.17%
VONV0.17%
ESGV0.15%
SCHX0.14%
SPLG0.13%
IVV0.13%
SCHB0.13%
ITOT0.11%
VONE0.11%
VOO0.11%
URTH0.10%
VTI0.10%
SPY0.10%
QUS0.09%
SPTM0.09%
ACWI0.08%
VT0.06%
IWF0.06%
VONG0.05%

LLY found in:

XLV15.40%
IYH13.72%
VHT12.15%
VIG3.33%
SCHG3.17%
QUAL2.92%
MGK2.82%
IWF2.66%
VONG2.42%
SPYG2.36%
VUG2.31%
IVW2.23%
QUS1.95%
XPH1.90%
ESGV1.48%
DGRW1.46%
IVV1.46%
SCHX1.34%
SPY1.29%
ITOT1.29%
SCHB1.25%
VFQY1.23%
VOO1.20%
SPTM1.20%
VTI1.14%
VONE1.14%
SPLG1.10%
ARKG1.04%
URTH0.99%
ACWI0.87%
VT0.66%
VFMO0.46%
RSP0.20%
ONEO0.02%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

HCA vs LLY: Head-to-Head Analysis

HCA Healthcare, Inc. (HCA) and Eli Lilly and Company (LLY) represent two companies in the Healthcare sector. Our quantitative Tale of the Tape shows these companies are evenly matched across profitability, valuation, and risk metrics.

In terms of capital efficiency, HCA generates a return on invested capital (ROIC) of 21.5% compared to LLY's 30.4%. This suggests LLY is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between HCA and LLY is -0.005, indicating low correlation, making them an effective diversification pair in a portfolio context.

HCA appears in 30 ETFs tracked by SecuritiesDB, while LLY appears in 34 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, HCA or LLY?

Our quantitative analysis compares HCA and LLY across nine fundamental dimensions. HCA and LLY are evenly matched across key metrics. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are HCA and LLY correlated?

The 252-day correlation between HCA and LLY is -0.005. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.